How should circular nucleotide sequences be represented in patent applications?
According to MPEP 2412.05(b), circular nucleotide sequences in patent applications should be represented as follows: The applicant must choose the nucleotide in residue position number 1 Numbering is continuous throughout the entire sequence in the 5′ to 3′ direction The last residue position number must equal the total number of nucleotides in the sequence The…
Read More